Details of the Drug-Related molecule(s) Expression Atlas
General Information of Drug (ID: DMXFLMK)
| Drug Name | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synonyms |
4-{[(Cyclohexylamino)carbonyl]amino}butanoic acid; 4-{[(CYCLOHEXYLAMINO)CARBONYL]AMINO}BUTANOIC ACID; 4-[(cyclohexylcarbamoyl)amino]butanoic acid; 511552-46-8; 4-(3-Cyclohexyl-ureido)-butyric acid; CHEMBL219695; 4-([(Cyclohexylamino)carbonyl]amino)butanoic acid; 4-(3-CYCLOHEXYLURIEDO)-BUTYRIC ACID; NC4; 1zd3; AC1O4WJY; AC1Q75I7; SCHEMBL1065092; WSVFRGGLURJIMG-UHFFFAOYSA-N; MolPort-004-290-136; HMS3604L06; ZINC8754389; BDBM50192936; AKOS000125413; 4-(3-cyclohexylur-eido)-butyric acid; NE13821; MCULE-1918218076; DB08257
|
|||||||||||||||||||
| Indication |
|
|||||||||||||||||||
| Cross-matching ID | ||||||||||||||||||||
Molecule(s) Related to This Drug
![]() Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
The Expression Level of Molecule(s) in Normal Tissue of Major ADME-Related Organs
|
||||||||||||||||||||||||||
| Molecule Expression Atlas in Normal Tissue of Major ADME-related organs | ||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
The Expression Level of Molecule(s) between Disease Section and Healthy Individual Tissue
| The Studied Disease | Discovery agent | |||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ICD Disease Classification | N.A. | |||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
| Molecular Expression Atlas between Disease Section and Healthy Individual Tissue | ||||||||||||||||||||||||||||||

